NCT00659828View on ClinicalTrials.gov

Effects of Leptin Replacement in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

April 16, 2010

Study Completion Date

April 16, 2010

Conditions
ObesityMetabolic SyndromeDiabetes
Interventions
DRUG

Recombinant methionyl human leptin

Recombinant methionyl human leptin, subcutaneous, once a day, 0.02 to 0.04 mg/kg (adjusted according to weight loss), indeterminate duration.

Trial Locations (1)

33132

University of Miami, Center on Pharmacogenomics, Miami

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Miami

OTHER

NCT00659828 - Effects of Leptin Replacement in Children | Biotech Hunter | Biotech Hunter